Virologic versus immunologic monitoring and the rate of accumulated genotypic resistance to first-line antiretroviral drugs in Uganda (Q34523909)

2 August 2017

title

Virologic versus immunologic monitoring and the rate of accumulated genotypic resistance to first-line antiretroviral drugs in Uganda (English)

1 reference

2 August 2017

0 references

0 references

anti-retroviral agent

0 references

6

Moses Kamya

1 reference

2 August 2017

7

Thomas C Quinn

1 reference

2 August 2017

5

Immaculate Nankya

1 reference

2 August 2017

1

Steven J Reynolds

1 reference

2 August 2017

9

Andrew Kambugu

1 reference

2 August 2017

4

Barbara Castelnuovo

1 reference

2 August 2017

Hakim Sendagire

2

1 reference

2 August 2017

Kevin Newell

series ordinal

3

1 reference

2 August 2017

Yukari C Manabe

series ordinal

8

1 reference

2 August 2017

language of work or name

1 reference

27 December 2012

1 reference

2 August 2017

published in

BMC Infectious Diseases

1 reference

2 August 2017

volume

12

1 reference

2 August 2017

page(s)

381

1 reference

Creative Commons Attribution 2.0 Generic

2 August 2017

copyright license

start time

1 December 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

2011 update of the drug resistance mutations in HIV-1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3548731

Alternative antiretroviral monitoring strategies for HIV-infected patients in east Africa: opportunities to save more lives?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3548731

Outcomes of antiretroviral treatment in programmes with and without routine viral load monitoring in Southern Africa.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3548731

Baseline severe anaemia should not preclude use of zidovudine in antiretroviral-eligible patients in resource-limited settings

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3548731

Evolution of Drug Resistance During 48 Weeks of Zidovudine/Lamivudine/Tenofovir in the Absence of Real-Time Viral Load Monitoring

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3548731

Second-line treatment in the Malawi antiretroviral programme: high early mortality, but good outcomes in survivors, despite extensive drug resistance at baseline

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3548731

Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3548731

Genotypic HIV type-1 drug resistance among patients with immunological failure to first-line antiretroviral therapy in south India

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3548731

Cause-specific mortality and the contribution of immune reconstitution inflammatory syndrome in the first 3 years after antiretroviral therapy initiation in an urban African cohort

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3548731

Diagnosis of antiretroviral therapy failure in Malawi: poor performance of clinical and immunological WHO criteria

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3548731

The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3548731

Failure of immunologic criteria to appropriately identify antiretroviral treatment failure in Uganda

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3548731

CD4+ T-cell count monitoring does not accurately identify HIV-infected adults with virologic failure receiving antiretroviral therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3548731

Evaluation of the WHO criteria for antiretroviral treatment failure among adults in South Africa

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3548731

Ordered appearance of zidovudine resistance mutations during treatment of 18 human immunodeficiency virus-positive subjects

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3548731

HIV viral load monitoring in resource-limited regions: optional or necessary?

7 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-381

Unnecessary antiretroviral treatment switches and accumulation of HIV resistance mutations; two arguments for viral load monitoring in Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-381

Accumulation of HIV drug resistance mutations in patients failing first-line antiretroviral treatment in South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-381

Promoting adherence to antiretroviral therapy: the experience from a primary care setting in Khayelitsha, South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-381

Monitoring of HIV viral loads, CD4 cell counts, and clinical assessments versus clinical monitoring alone for antiretroviral therapy in rural district hospitals in Cameroon (Stratall ANRS 12110/ESTHER): a randomised non-inferiority trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-381

Economic evaluation of monitoring virologic responses to antiretroviral therapy in HIV-infected children in resource-limited settings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-381

High rate of misclassification of treatment failure based on WHO immunological criteria

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23270482

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-2334-12-381

1 reference

Dimensions Publication ID

2 August 2017

0 references

1 reference

2 August 2017

1 reference